FDA.reportPublic FDA data

atezolizumab 1200 MG in 20 ML Injection

RxCUI
1792780
RxNorm name
atezolizumab 1200 MG in 20 ML Injection
Display name
atezolizumab 1200 MG in 20 ML Injection
Full name
atezolizumab 1200 MG in 20 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761034Tecentriqatezolizumab351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6fa682c9-a312-4932-9831-f286908660eeatezolizumab 1200 MG in 20 ML Injection [PSN] · 20 ML atezolizumab 60 MG/ML Injection [SCD] · atezolizumab 1200 MG per 20 ML Injection [SY]345These highlights do not include all the information needed to use TECENTRIQ safely and effectively. See full prescribing information for TECENTRIQ. TECENTRIQ ® (atezolizumab) injection, for intravenous use Initial U.S. Approval: 201620260520